Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer

Cancer Prevention Research

Volumn 7, Issue 4, 2014, Pages 418-425

  Braganza, Melissa Z ^a   De González, Amy Berrington ^a   Schonfeld, Sara J ^b   Wentzensen, Nicolas ^a   Brenner, Alina V ^a   Kitahara, Cari M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST DISEASE; CANCER RISK; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HORMONAL THERAPY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; SELF REPORT; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; UTERUS MYOMA; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, PAPILLARY; COMPLICATION; ESTROGEN THERAPY; GENITAL DISEASES, FEMALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REPRODUCTIVE HISTORY; RISK FACTOR; THYROID NEOPLASMS;

AGED; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GENITAL DISEASES, FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS; THYROID NEOPLASMS;

EID: 84898865907     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0367     Document Type: Article

References (49)

1. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JFJr, editors. Cancer epidemiology and prevention. Oxford: Oxford University Press; 2006. p. 975-94.
2. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol 2010;6:1771-9.
3. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Current Cancer Drug Targets 2008;8:367-77.
4. Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, et al. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010;20:33-41.
5. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLOS ONE 2012;7: e29177.
6. Meisner AL, Fekrazad MH, Royce ME. Breast disease: benign and malignant. Med Clin North Am 2008;92:1115-41, x.
7. Petraglia F, Musacchio C, Luisi S, De Leo V. Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment. Best Pract Res Clin Obstet Gynaecol 2008;22: 235-49. (Pubitemid 351292327)
8. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS, et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010;171:242-52.
9. Schonfeld SJ, Ron E, Kitahara CM, Brenner A, Park Y, Sigurdson AJ, et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol 2011;35:e85-90.
10. Melin A, Sparen P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007;22:3021-6. (Pubitemid 351696799)
11. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005;16:500-7. (Pubitemid 40847834)
12. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 1997;19:310-27. (Pubitemid 28099778)
13. Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. ObstetGynecol 1995;86:764-9.
14. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37. (Pubitemid 41058322)
15. Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev 2005;14:2929-35. (Pubitemid 43068827)
16. Spinos N, Terzis G, Crysanthopoulou A, Adonakis G, Markou KB, Vervita V, et al. Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids. Thyroid 2007;17: 1257-9.
17. Kim MH, Park YR, Lim DJ, Yoon KH, Kang MI, Cha BY, et al. The relationship between thyroid nodules and uterine fibroids. Endocr J 2010;57:615-21.
18. Rice KE, Secrist JR, Woodrow EL, Hallock LM, Neal JL. Etiology, diagnosis, and management of uterine leiomyomas. J Midwifery Women's Health 2012;57:241-7.
19. Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 2013; 34:130-62.
20. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:273S-309S.
21. IARC. Cancer incidence in five continents. Vol. IX. France: IARC Scientific Publications; 2008. p. 1-837.
22. De Stavola BL, Wang DY, Allen DS, Giaconi J, Fentiman IS, Reed MJ, et al. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom). Cancer Causes Control 1993;4:331-40. (Pubitemid 23205743)
23. Chavez-MacGregor M, Elias SG, Onland-Moret NC, van der Schouw YT, Van Gils CH, Monninkhof E, et al. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev 2005;14:799-804. (Pubitemid 40478538)
24. Schildkraut JM, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997;89:932-8. (Pubitemid 27282065)
25. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001;93:745-50. (Pubitemid 32695128)
26. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10:143-55. (Pubitemid 29161106)
27. Truong T, Orsi L, Dubourdieu D, Rougier Y, Hemon D, Guenel P. Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol 2005;161:1056-65. (Pubitemid 40734354)
28. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev 2011;20: 1751-9.
29. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999;10:157-66. (Pubitemid 29161107)
30. Kabat GC, Kim MY, Wactawski-Wende J, Lane D, Wassertheil-Smoller S, Rohan TE. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control 2012;23:2031-40.
31. Przybylik-Mazurek E, Hubalewska-Dydejczyk A, Fedorowicz A, Pach D. Factors connected with the female sex seem to play an important role in differentiated thyroid cancer. Gynecol Endocrinol 2011;27: 961-5.
32. Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E, et al. Risk factors for thyroid cancer in northern Italy. Int J Epidemiol 1989;18:578-84. (Pubitemid 19268599)
33. Ron E, Kleinerman RA, Boice JDJr, LiVolsi VA, Flannery JT, Fraumeni JFJr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst 1987;79:1-12. (Pubitemid 17102544)
34. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411-23. (Pubitemid 40895468)
35. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-72. (Pubitemid 30461140)
36. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;127:442-51.
37. Schuler S, Ponnath M, Engel J, Ortmann O. Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet 2013;287:1187-204.
38. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Revi 1993;15:36-47. (Pubitemid 23269069)
39. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002;13:831-8. (Pubitemid 35305202)
40. Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003; 158:629-38. (Pubitemid 37175510)
41. Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 2002;13:807-11. (Pubitemid 35305199)
42. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40. (Pubitemid 33585924)
43. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
44. Lee ML, Chen GG, Vlantis AC, Tse GM, Leung BC, van Hasselt CA. Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J 2005;11: 113-21. (Pubitemid 44698822)
45. Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions. Pol J Pathol 2002;53:67-72.
46. Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control 1995;6:217-24.
47. Ness RB, Buhari A, Gutai J, Kuller LH. Reproductive history in relation to plasma hormone levels in healthy post-menopausal women. Maturitas 2000;35:149-57. (Pubitemid 30642832)
48. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:47-59. (Pubitemid 32125900)
49. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev 2004;13:1296-301. (Pubitemid 39071552)